German maker of glass and plastic packaging and drug-delivery devices such as vials, syringes and bottles for pharma and cosmetics.
German maker of glass and plastic packaging and drug-delivery devices such as vials, syringes and bottles for pharma and cosmetics.
Sells packaging and delivery devices that become part of a medicine's regulatory approval, so once a drug is launched in its vial or syringe, switching is slow. Glass-making is energy-hungry, so furnace running costs weigh on margins, and plants need large, ongoing investment.
In one line: A German, packaging-focused smaller West Pharmaceutical Services.
Moat: narrow (regulatory licence, customer qualification, scale). Pharma-grade manufacturing qualifications create high switching costs, but capital-intensive glass/plastic manufacturing is competitive.
Headquarters: Duesseldorf, Germany · Founded: 1864 · Employees: 13,528
Size Gerresheimer (GXI.DE) is a Germany Materials company (Containers/Packaging) with a market value of $1.26B, the 128th largest of 198 Germany companies the cockpit tracks. Shares closed at €33.20 on 18 Nov 2026.
Performance Over six months the shares gained 21.3%, against -2.7% for the median peer and -0.9% for the Germany market (cap-weighted) — 5th highest of 21 in its peer set.
Growth Revenue grew 8.9% over the last twelve months (peer median +0.6%); the operating margin is -4.1% (peer median 7.4%).
Valuation It trades at 16.0× forward earnings against a peer median of 16.2× (10th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about 57% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is +47 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 7.4 points below its cost of capital (5.2% WACC).
Next results Next results expected around 25 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | €2.28B | €2.32B | €1.99B | €1.99B | €1.82B |
| Revenue growth | — | +17% | 0% | +10% | — |
| Gross profit | €348M | €495M | €502M | €551M | €500M |
| EBITDA | €434M | €377M | €358M | €396M | €350M |
| Net income | -€401M | -€320M | €82.3M | €116M | €96.1M |
| Free cash flow | €7.88M | -€98.8M | -€130M | -€33.4M | -€15.9M |
| Capital expenditure | €254M | €308M | €370M | €328M | €238M |
| Total debt | €2.21B | €2.18B | €1.28B | €1.05B | €1.23B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Gerresheimer GXI.DE | $1.26B | +21% | +9% | -4% | 16.0× | 57.0% |
| West Pharmaceutical Services WST | $28.1B | +32% | +13% | 23% | 40.2× | 25.8% |
| SCHOTT Pharma AG & Co. KGaA 1SXP.DE | $3.73B | +32% | +4% | 15% | 23.0× | 12.7% |
| Corning GLW | $93.2B | -40% | +19% | 17% | 25.7× | 25.6% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | GXI.DE | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +1.3% | -2.7% | 8th highest of 21 |
| 6-month return | +21.3% | -2.7% | 5th highest of 21 |
| Distance from 52-week high | -2.9% | -33.0% | highest of 21 |
| Revenue growth (TTM) | +8.9% | +0.6% | 5th highest of 21 |
| Operating margin | -4.1% | 7.4% | lowest of 21 |
| Forward P/E | 16.0× | 16.2× | 10th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | 57.0% | 2.6% | most demanding of 12 |
| Growth delivered (Del g) | +10.3% | +5.5% | 2nd highest of 12 |
| Hurdle (Req g minus delivered) | +46.7 pp | +1.6 pp | most demanding of 12 |
| ROIC minus cost of capital | -7.4 pp | -0.6 pp | 2nd lowest of 21 |
| EV / EBITDA | 7.4× | 7.3× | 4th most expensive of 8 |
| Net debt / EBITDA | 4.7× | 1.6× | most indebted of 8 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Gerresheimer GXI.DE | Germany | $1.26B | +21% | +9% | -4% | 16.0× | 57.0% | +10.3% |
| Shanghai Shunho New Materials Technology 002565.SZ | China | $1.30B | -55% | -15% | -3% | n/a | n/a | n/a |
| Orora ORA.AX | Australia | $1.30B | +21% | +6% | 11% | 15.4× | 2.6% | -8.9% |
| Fuji Seal International 7864.T | Japan | $1.19B | +31% | +7% | 9% | 11.0× | n/a | n/a |
| TriMas TRS | United States | $1.34B | -3% | -33% | 4% | 19.0× | n/a | n/a |
| Shenzhen Leaguer 002243.SZ | China | $1.17B | -26% | +5% | -3% | 18.5× | 43.3% | +1.6% |
| Jiangsu Hualan New Pharmaceutical Material 301093.SZ | China | $1.35B | -46% | +6% | 5% | 68.3× | 47.9% | +6.7% |
| Zhejiang Great Shengda Packing 603687.SS | China | $1.16B | -2% | +1% | 3% | 38.1× | n/a | n/a |
| Jiamei Food Packaging (Chuzhou) 002969.SZ | China | $1.41B | -63% | -10% | 6% | 78.2× | 20.5% | +7.3% |
| Shenzhen Changhong Technology 300151.SZ | China | $1.12B | -26% | -1% | 6% | 54.7× | n/a | n/a |
| Taiwan Hon Chuan Enterprise 9939.TW | Taiwan | $1.07B | -6% | +1% | 15% | 9.7× | -4.0% | +8.3% |
| Cascades CAS.TO | Canada | $1.07B | +45% | 0% | 5% | 8.7× | -1.0% | +3.1% |
| Huangshan Novel 002014.SZ | China | $1.04B | +4% | +9% | 12% | 16.2× | n/a | n/a |
| Elopak ELO.OL | Norway | $1.01B | +8% | 0% | 9% | 12.2× | -7.7% | +7.7% |
| Time Technoplast TIMETECHNO.NS | India | $1.00B | +10% | +21% | 11% | 12.1× | n/a | n/a |
| Shanghai Zijiang Enterprise 600210.SS | China | $1.59B | +3% | -18% | 10% | 11.6× | n/a | n/a |
| Suzhou Hycan 002787.SZ | China | $996M | -40% | 0% | 7% | 33.2× | n/a | n/a |
| ORG Technology 002701.SZ | China | $1.62B | -20% | +24% | 5% | 10.2× | -5.3% | +15.8% |
| Zhejiang Zhongxin Environmental Protection Technology 603091.SS | China | $927M | -28% | +31% | 22% | 13.8× | 6.8% | +4.4% |
| MYS 002303.SZ | China | $905M | +23% | +1% | 8% | 18.5× | 4.9% | +3.4% |
| Shandong Pharmaceutical Glass 600529.SS | China | $1.78B | +1% | -9% | 18% | 16.4× | -3.0% | +5.5% |